Vendor, Fuquay Varina, NC
Collaborations Pharmaceuticals, Inc.
UEI EFJCLL37KKH3, CAGE 7BGW7
1 award and $1,999,195 obligated between September 29, 2025 and June 24, 2026, 100% under full and open competition, against 4.0 offers on average where reported. 12 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $1,999,195 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Collaborations Pharmaceuticals, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Collaborations Pharmaceuticals, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $1,999,195
- Soonest
- December 29, 2026
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to National Institutes of Health, by dollars.
| Fisher Bioservices Inc.Rockville, MD | $101,554,099 |
| PPD Development LPWilmington, NC | $65,307,629 |
| Seattle Children'S HospitalSeattle, WA | $61,525,979 |
| Alpha Genesis Inc.Yemassee, SC | $55,645,143 |
| Psychogenics Inc.Paramus, NJ | $36,035,836 |
| Rho Federal Systems Division Inc.Durham, NC | $35,268,211 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025C00039Definitive Contract, September 29, 2025, Full and Open Competition After Exclusion of Sources, 4 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | Is to Develop Pan-Influenza Inhibitors Targeting the PA Endonuclease from the Viral Replication Complex by Demonstrating Pyronaridine as a VNAICS 541714, PSC AN12 | $1,999,195 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards